Perspective Therapeutics (CATX) Receivables - Other (2010 - 2025)
Perspective Therapeutics' (CATX) quarterly Receivables - Other came in at $10000.0 in Q4 2025, down 97.95% year-over-year from $487000.0 in Q4 2024, and down 97.95% quarter-over-quarter from $487000.0 in Q4 2024.
Powered by 
Analysis
Perspective Therapeutics (CATX) Receivables - Other (2010 - 2025) Analysis & Trends
Perspective Therapeutics has disclosed Receivables - Other across 16 years of filings, most recently posting $10000.0 for Q4 2025.
- In Q4 2025, Receivables - Other fell 97.95% year-over-year to $10000.0; the TTM figure through Dec 2025 stood at $10000.0 (down 97.95% YoY), while the FY2025 annual figure was $10000.0, down 97.95% from the prior year.
- Receivables - Other came in at $10000.0 for Q4 2025 at Perspective Therapeutics, down from $487000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $487000.0 in Q4 2024 to a low of $2000.0 in Q4 2022.
- Average Receivables - Other over 5 years is $93000.0, with a median of $13500.0 recorded in 2022.
- Year-over-year, Receivables - Other surged 4770.0% in 2024 and tumbled 97.95% in 2025.
- Over 5 years, Receivables - Other stood at $32000.0 in 2021, then slumped by 93.75% to $2000.0 in 2022, then jumped by 400.0% to $10000.0 in 2023, then surged by 4770.0% to $487000.0 in 2024, then plunged by 97.95% to $10000.0 in 2025.
- Per Business Quant data, the three most recent Receivables - Other figures were $10000.0 in Q4 2025, $487000.0 in Q4 2024, and $10000.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Perspective Therapeutics | 361.95 Mn | 361.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 487,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Jun 30, 2021 | 32,000.00 |
| Jun 30, 2020 | 31,000.00 |
| Jun 30, 2019 | 86,000.00 |
| Jun 30, 2018 | 41,000.00 |
| Jun 30, 2017 | 67,000.00 |
| Jun 30, 2016 | -4,990.00 |
| Mar 31, 2016 | 5,098.00 |
| Dec 31, 2015 | 8,715.00 |
| Sep 30, 2015 | 10,406.00 |
| Jun 30, 2015 | 9,687.00 |
| Mar 31, 2015 | 9,928.00 |
| Dec 31, 2014 | 10,978.00 |
| Sep 30, 2014 | -47,824.00 |
| Jun 30, 2014 | 46,096.00 |
| Mar 31, 2014 | -3,078.00 |